JAWAD AGHA: Open Payments
NPI 1235164872 · HAZEL PARK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 91 payments from 17 companies in 2025. Trend: 2023 $570 · 2024 $1,028 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $362 |
| AstraZeneca Pharmaceuticals LP | 13 | $265 |
| Alkermes, Inc. | 18 | $200 |
| Axsome Therapeutics, Inc. | 9 | $179 |
| PFIZER INC. | 6 | $112 |
| Novo Nordisk Inc | 5 | $91 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Corcept Therapeutics | 3 | $80 |
| ABBVIE INC. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
Products named: CAPLYTA, ARISTADA, AIRSUPRA, Symbravo, REXULTI, NURTEC ODT, TRELEGY ELLIPTA, Korlym.
Industry payments across MI — which companies pay providers there.
